Conclusions: ATM kinase-MAD2B axis importantly contributes to the cell cycle reentry of podocytes, which is a novel pathogenic mechanism of FSGS, and may shed light on the development of its therapeutic approaches. The gene discussed is MAD2L2; the disease is focal segmental glomerulosclerosis.